tiprankstipranks
Trending News
More News >
Elite Pharmaceuticals (ELTP)
OTHER OTC:ELTP
US Market
Advertisement

Elite Pharmaceuticals (ELTP) Ratios

Compare
337 Followers

Elite Pharmaceuticals Ratios

ELTP's free cash flow for Q4 2025 was $0.54. For the 2025 fiscal year, ELTP's free cash flow was decreased by $ and operating cash flow was $0.61. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
4.88 3.07 2.75 2.82 2.10
Quick Ratio
3.50 2.08 1.53 1.81 1.24
Cash Ratio
0.96 0.54 1.00 1.28 0.55
Solvency Ratio
-0.05 0.83 369.58 1.04 0.66
Operating Cash Flow Ratio
0.63 -0.25 0.43 0.97 0.55
Short-Term Operating Cash Flow Coverage
1.76 -0.76 10.74 18.39 7.77
Net Current Asset Value
$ 14.87M$ 13.94M$ 9.57M$ 8.93M$ 2.16M
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.14 0.10 0.08 0.09
Debt-to-Equity Ratio
0.20 0.20 0.13 0.11 0.15
Debt-to-Capital Ratio
0.17 0.17 0.12 0.10 0.13
Long-Term Debt-to-Capital Ratio
0.05 0.05 0.11 0.05 0.10
Financial Leverage Ratio
1.80 1.45 1.41 1.39 1.62
Debt Service Coverage Ratio
-0.28 4.55 302.38 14.67 10.25
Interest Coverage Ratio
25.38 18.33 1.82K 26.44 8.11
Debt to Market Cap
0.01 0.05 0.13 0.05 0.04
Interest Debt Per Share
0.01 0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
-0.14 1.79 -0.61 -0.92 -0.14
Profitability Margins
Gross Profit Margin
47.70%46.55%48.58%45.86%46.76%
EBIT Margin
0.86%1.86%0.01%15.72%8.29%
EBITDA Margin
3.38%4.56%0.02%19.42%23.36%
Operating Profit Margin
23.32%19.05%5.93%15.72%8.29%
Pretax Profit Margin
-0.06%0.82%11.67%19.54%16.33%
Net Profit Margin
-5.13%35.51%12.91%27.58%20.05%
Continuous Operations Profit Margin
-5.13%35.51%0.01%27.58%20.05%
Net Income Per EBT
8275.14%4342.25%110.64%141.14%122.77%
EBT Per EBIT
-0.27%4.29%196.82%124.33%196.93%
Return on Assets (ROA)
-4.48%24.04%10783.21%25.32%19.43%
Return on Equity (ROE)
-8.83%34.92%15227.43%35.28%31.50%
Return on Capital Employed (ROCE)
23.18%15.28%6125.12%17.82%10.33%
Return on Invested Capital (ROIC)
1809.64%619.48%6710.61%22.29%12.32%
Return on Tangible Assets
-4.75%26.01%12762.06%31.21%26.02%
Earnings Yield
-0.69%12.94%15012.72%25.19%8.99%
Efficiency Ratios
Receivables Turnover
2.88 2.91 11.04K 10.55 7.26
Payables Turnover
14.86 11.15 7.18K 12.21 14.54
Inventory Turnover
2.71 2.34 1.84K 2.59 2.70
Fixed Asset Turnover
5.96 3.88 3.27K 4.62 3.70
Asset Turnover
0.87 0.68 835.17 0.92 0.97
Working Capital Turnover Ratio
2.12 2.79 2.64K 3.48 6.35
Cash Conversion Cycle
237.14 248.59 0.18 145.56 160.57
Days of Sales Outstanding
126.85 125.39 0.03 34.60 50.28
Days of Inventory Outstanding
134.85 155.93 0.20 140.87 135.40
Days of Payables Outstanding
24.56 32.73 0.05 29.90 25.11
Operating Cycle
261.70 281.32 0.23 175.47 185.68
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 >-0.01 <0.01 <0.01 <0.01
Free Cash Flow Per Share
<0.01 >-0.01 >-0.01 <0.01 <0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
0.66 1.25 -0.72 0.92 0.90
Dividend Paid and CapEx Coverage Ratio
2.95 -4.05 0.58 13.05 9.68
Capital Expenditure Coverage Ratio
2.95 -4.05 0.58 13.05 9.68
Operating Cash Flow Coverage Ratio
0.68 -0.28 0.86 2.34 1.34
Operating Cash Flow to Sales Ratio
0.09 -0.06 <0.01 0.20 0.13
Free Cash Flow Yield
0.79%-2.63%-8.16%17.01%5.06%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-144.61 7.73 <0.01 3.97 11.12
Price-to-Sales (P/S) Ratio
7.42 2.74 <0.01 1.09 2.23
Price-to-Book (P/B) Ratio
11.66 2.70 1.01 1.40 3.50
Price-to-Free Cash Flow (P/FCF) Ratio
126.55 -37.97 -12.25 5.88 19.76
Price-to-Operating Cash Flow Ratio
83.68 -47.34 8.80 5.43 17.72
Price-to-Earnings Growth (PEG) Ratio
-1.91 -0.08 <0.01 0.06 -0.04
Price-to-Fair Value
11.66 2.70 1.01 1.40 3.50
Enterprise Value Multiple
219.37 61.95 3.96 4.72 9.41
Enterprise Value
623.58M 159.99M 25.43M 29.57M 55.77M
EV to EBITDA
219.37 61.95 3.96 4.72 9.41
EV to Sales
7.42 2.83 <0.01 0.92 2.20
EV to Free Cash Flow
126.47 -39.11 -10.60 4.92 19.47
EV to Operating Cash Flow
83.64 -48.76 7.62 4.54 17.46
Tangible Book Value Per Share
0.04 0.05 0.02 0.02 0.01
Shareholders’ Equity Per Share
0.05 0.06 0.03 0.02 0.02
Tax and Other Ratios
Effective Tax Rate
-81.75 -42.42 -0.11 -0.28 -0.23
Revenue Per Share
0.08 0.06 33.72 0.03 0.03
Net Income Per Share
>-0.01 0.02 4.35 <0.01 <0.01
Tax Burden
82.75 43.42 1.11 1.41 1.23
Interest Burden
-0.07 0.44 781.76 1.24 1.97
Research & Development to Revenue
0.09 0.12 0.18 0.13 0.20
SG&A to Revenue
0.11 0.12 0.15 0.14 0.13
Stock-Based Compensation to Revenue
<0.01 0.15 <0.01 0.02 0.04
Income Quality
-1.73 -0.16 0.94 0.73 0.63
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis